Journal: EMBO Mol Med / Year: 2025 Title: Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome. Authors: Rosalie Matico / Karolien Grauwen / Dhruv Chauhan / Xiaodi Yu / Irini Abdiaj / Suraj Adhikary / Ine Adriaensen / Garcia Molina Aranzazu / Jesus Alcázar / Michela Bassi / Ellen Brisse / ...Authors: Rosalie Matico / Karolien Grauwen / Dhruv Chauhan / Xiaodi Yu / Irini Abdiaj / Suraj Adhikary / Ine Adriaensen / Garcia Molina Aranzazu / Jesus Alcázar / Michela Bassi / Ellen Brisse / Santiago Cañellas / Shubhra Chaudhuri / Francisca Delgado / Alejandro Diéguez-Vázquez / Marc Du Jardin / Victoria Eastham / Michael Finley / Tom Jacobs / Ken Keustermans / Robert Kuhn / Josep Llaveria / Jos Leenaerts / Maria Lourdes Linares / Maria Luz Martín / Rosa Martín-Pérez / Carlos Martínez / Robyn Miller / Frances M Muñoz / Michael E Muratore / Amber Nooyens / Laura Perez-Benito / Mathieu Perrier / Beth Pietrak / Jef Serré / Sujata Sharma / Marijke Somers / Javier Suarez / Gary Tresadern / Andres A Trabanco / Dries Van den Bulck / Michiel Van Gool / Filip Van Hauwermeiren / Teena Varghese / Juan Antonio Vega / Sameh A Youssef / Matthew J Edwards / Daniel Oehlrich / Nina Van Opdenbosch / Abstract: The NLRP3 inflammasome plays a pivotal role in host defense and drives inflammation against microbial threats, crystals, and danger-associated molecular patterns (DAMPs). Dysregulation of NLRP3 ...The NLRP3 inflammasome plays a pivotal role in host defense and drives inflammation against microbial threats, crystals, and danger-associated molecular patterns (DAMPs). Dysregulation of NLRP3 activity is associated with various human diseases, making it an attractive therapeutic target. Patients with NLRP3 mutations suffer from Cryopyrin-Associated Periodic Syndrome (CAPS) emphasizing the clinical significance of modulating NLRP3. In this study, we present the identification of a novel chemical class exhibiting selective and potent inhibition of the NLRP3 inflammasome. Through a comprehensive structure-activity relationship (SAR) campaign, we optimized the lead molecule, compound A, for in vivo applications. Extensive in vitro and in vivo characterization of compound A confirmed the high selectivity and potency positioning compound A as a promising clinical candidate for diseases associated with aberrant NLRP3 activity. This research contributes to the ongoing efforts in developing targeted therapies for conditions involving NLRP3-mediated inflammation, opening avenues for further preclinical and clinical investigations.
Macromolecule #1: Maltose/maltodextrin-binding periplasmic protein,NACHT, LRR and P...
Macromolecule
Name: Maltose/maltodextrin-binding periplasmic protein,NACHT, LRR and PYD domains-containing protein 3 chimera type: protein_or_peptide / ID: 1 / Number of copies: 4 / Enantiomer: LEVO EC number: Hydrolases; Acting on acid anhydrides; Acting on acid anhydrides to facilitate cellular and subcellular movement
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi